Organigram stock faces Nasdaq listing compliance notice
Published on 11/19/2026 at 04:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey investor takeaways
- Nasdaq trading continues while Organigram works to restore compliance.
- The Toronto listing is unaffected by the notice.
- The company combines Canadian adult-use cannabis operations with European medical-cannabis activities.
Organigram Global said on November 13 that it had received a Nasdaq compliance notice on November 11 after its common shares closed below US$1.00 for 30 consecutive business days. The announcement was reported by Morningstar.
Nasdaq sets compliance timetable
The notice has no immediate effect on the listing or trading of Organigram's common shares on the Nasdaq Global Select Market. The company has 180 calendar days, until May 10, 2027, to regain compliance by recording a closing bid of at least US$1.00 for 10 consecutive business days.
Nasdaq may grant an additional 180-day compliance period if Organigram meets the applicable requirements, including a possible transfer to the Nasdaq Capital Market. If the company does not qualify for that extension or otherwise regain compliance, its shares could become subject to delisting proceedings and related appeal rights.
The notice does not affect Organigram's listing or compliance status on the Toronto Stock Exchange. For investors, the immediate issue is therefore a Nasdaq listing requirement rather than a suspension of trading.
Organigram's operating footprint
Organigram Global cultivates and processes cannabis for adult-use consumers in Canada and participates in Germany's medical-cannabis market and other emerging European markets through Sanity Group. Its brand portfolio includes Edison, Big Bag O' Buds, SHRED, Monjour, Tremblant, Collective Project, Trailblazer, BOXHOT and DEBUNK.
The company is headquartered in Toronto and operates facilities in New Brunswick, Quebec, Manitoba and Ontario. Its investor page describes the business as a Canadian cannabis platform with European operations and regulated production assets.
Organigram Global at a glance
- Company: Organigram Global Inc.
- ISIN: CA68620P1018
- Ticker: OGI
- Home exchanges: Nasdaq Global Select Market and Toronto Stock Exchange
- Compliance deadline: May 10, 2027
Organigram operates within the Canadian equity market environment tracked by the S&P/TSX Composite.
More news and analyses on Organigram Global stock.
